Biomarkers related to immunotherapy efficacy

TW202631989APending Publication Date: 2026-08-01KITE PHARMA INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-11-03
Publication Date
2026-08-01

Smart Images

  • Figure TWG2TA001071018_001
    Figure TWG2TA001071018_001
  • Figure TWG2TA001071018_002
    Figure TWG2TA001071018_002
  • Figure TWG2TA001071018_003
    Figure TWG2TA001071018_003
Patent Text Reader

Abstract

The disclosure relates to methods for predicting a likelihood of a relapse to a cancer in a patient following treatment of the patient with an immunotherapy product, and methods for improving efficacy of an immunotherapy product for a patient with a likelihood of a relapse to a cancer following treatment with an immunotherapy product.
Need to check novelty before this filing date? Find Prior Art